An anonymous director reports

RAVENQUEST PROVIDES BIWEEKLY STATUS UPDATE

Ravenquest Biomed Inc. has released its biweekly status update on the delay of filing its annual financial statements and accompanying management's discussion and analysis (MD&A) for the financial year ended Oct. 31, 2019. As previously announced on March 2, 2020, the company expects to file the annual filings on or before May 1, 2020.

The company also reports that due to restricted or no access to the company's Edmonton facility, Health Canada has revoked the Alberta Green Biotech licence. Further details are disclosed in the company's March 20, 2020, news release.

Ravenquest management confirms that it is working diligently to meet the company's obligations relating to its annual filings. Since the company announced a delay of its annual filings, there has been no material change to the information set out in the filings notice that has not been generally disclosed and there has been no failure by the company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in National Policy 12-203, Management Cease Trade Orders. While subject to a management cease trader under NP 12-203, the company will continue to comply with the provisions of the alternative information guidelines under NP 12-203 by issuing biweekly status reports until it has satisfied the necessary filing requirements.

About Ravenquest Biomed Inc.

Ravenquest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services and consulting, and specialized research and development. Ravenquest is a licensed producer with facilities located in Markham, Ont., and Edmonton, Alta.

We seek Safe Harbor.